期刊文献+

Synthesis,Crystal Structure and Characterization of3-Ethyl-3,4,4a,10a-tetrahydro-2H-1,5-dioxa-3-aza-phenanthren-6-one:C_(13)H_(13)NO_3

Synthesis,Crystal Structure and Characterization of 3-Ethyl-3,4,4a,10a-tetrahydro-2H-1,5-dioxa3-aza-phenanthren-6-one:C_(13)H_(13)NO_3
下载PDF
导出
摘要 3-Ethyl-3,4,4a, 10a-tetrahydro-2H- 1,5-dioxa-3-aza-phenanthren-6-one (C13H13NO3, Mr = 231.24) was synthesized and characterized by FT-IR, H NMR spectra, and thermal analysis. The crystal structure was determined by X-ray single-crystal diffraction. It crystallizes in methanol. The crystal is of orthorhombic system, space group Pbca with a = 8.9250(18), b = 12.605(3), c = 20.552(4) A, Z = 8, V = 2312.1(8) A3, Dc = 1.329 mg/m3, p = 0.095 mm-, F(000) = 976, R = 0.0583 and wR = 0.1340. Thermal analysis reveals that it is stable below 100 C. Fluorescence spectra analysis shows that its fluorescence intensity is twice as that of 7-hydroxylcoumarin in methanol solution with the same concentration. 3-Ethyl-3,4,4a, 10a-tetrahydro-2H- 1,5-dioxa-3-aza-phenanthren-6-one (C13H13NO3, Mr = 231.24) was synthesized and characterized by FT-IR, H NMR spectra, and thermal analysis. The crystal structure was determined by X-ray single-crystal diffraction. It crystallizes in methanol. The crystal is of orthorhombic system, space group Pbca with a = 8.9250(18), b = 12.605(3), c = 20.552(4) A, Z = 8, V = 2312.1(8) A3, Dc = 1.329 mg/m3, p = 0.095 mm-, F(000) = 976, R = 0.0583 and wR = 0.1340. Thermal analysis reveals that it is stable below 100 C. Fluorescence spectra analysis shows that its fluorescence intensity is twice as that of 7-hydroxylcoumarin in methanol solution with the same concentration.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2013年第10期1503-1508,共6页 结构化学(英文)
基金 Supported by NNSFC(No.20974045)
关键词 crystal growth fluorescence coumarin derivatives bezoxazine crystal growth, fluorescence, coumarin derivatives, bezoxazine
  • 相关文献

参考文献2

二级参考文献41

  • 1Mitra,A.K.;De,A.;Karchaudhuri,N.;Misra,S.K.;Mukhopadhyay,A.K.J.Ind.Chem.Soc.1998,75,666-671.
  • 2Romines,K.R.;Morris,J.K.;Howe,W.J.;Tomich,P.K.;Horng,M.M.;Chong,K.T.;Hinshaw,R.R.;Anderson,D.J.;Strohbach,J.W.;Turner,S.R.;Mizsak,S.A.J.Med.Chem.1996,39,4125-4130.
  • 3Zhao,H.;Neamati,N.;Hong,H.;Mazumder,A.;Wang,S.;Sunder,S.;Milne,G.W.A.;Pommier,Y.;Bruke,T.R J.J.Med.Chem.1997,40,242-249.
  • 4Skulnick,H.I.;Johnson,P.D.;Schwende,F.J.;Howard,G.M.;Zaya,R.M.;Dalga,R.J.;Williams,M.G.;Romines,K.R.J.Med.Chem.1997,40,1149-1152.
  • 5Jeanneret,V.;Vogel,P.;Renaut,P.;Millet,J.;Theveniaux,J.;Barberousse,V.Bioorg.Med.Chem.Lett.1998,8,1687-1688.
  • 6Takeuchi,Y.;Xie,L.;Cosentino,L.M.;Lee,K.H.Bioorg.Med.Chem.Lett.1997,7,2573-2578.
  • 7(a)Deana,A.A.J.Med.Chem.1983,26,580-585.(b)Wenkert,E.;Buckwalter,B.L.J.Am.Chem.Soc.1972,94,4367-4369.
  • 8Thaisrivongs,S.;Tomich P.K.;Watenpaugh,K.D.;Keith,D.;Chong,K.T.;Howe,W.J.;Yang,C.P.J.Med.Chem.1994,37,3200-3204.
  • 9Tummino,P.J.;Ferguson,D.;Hupe,D.Biochem.Biophys.Res.Commum.1994,201,290-294.
  • 10Tummino,P.J.;Ferguson,D.;Hupe,L.;Hupe,D.Biochem.Biophys.Res.Commun.1994,200,1658-1664.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部